INVESTOR ALERT: Levi & Korsinsky, LLP Announces Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of...
13 Maggio 2014 - 7:34PM
Business Wire
Levi & Korsinsky notifies investors of Furiex
Pharmaceuticals, Inc. (“Furiex” or “the Company”) (NasdaqGS: FURX)
of claims of breaches of fiduciary duty and other violations of
state law against the board of directors of the Company in
connection with the sale of the Company to Forest Laboratories,
Inc. (“Forest”). A complaint was filed in Delaware state court.
Click here to learn more about the investigation:
http://zlk.9nl.com/furiex-pharmaceuticals-furx, or call:
877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Furiex shareholders will
receive $95.00 per share in cash for each share of Furiex stock
they own. The transaction has a total approximate value of $1.1
billion. An additional $30.00 per share ($360 million in aggregate)
may be payable to shareholders in a Contingent Value Right (CVR)
based on the status of eluxodoline, Furiex’s lead product, as a
controlled drug following approval. The claims concern whether the
Furiex Board of directors breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether Forest is
underpaying for Furiex shares.
If you own Furiex common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit
http://zlk.9nl.com/furiex-pharmaceuticals-furx.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s 26
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
Grafico Azioni (MM) (NASDAQ:FURX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni (MM) (NASDAQ:FURX)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a (MM) (NASDAQ): 0 articoli recenti
Più Furiex Pharmaceuticals, Inc. (MM) Articoli Notizie